EBR Systems (EBRCZ) EBITDA Margin (2025 - 2026)
EBR Systems recorded quarterly EBITDA Margin of 684.67% in Q1 2026, down 128.39% quarter-over-quarter from 2411.82% in Q4 2025.
EBR Systems' EBITDA Margin history runs 2 years deep, the most recent figure standing at 684.67% for Q1 2026.
- In Q1 2026, EBITDA Margin changed N/A year-over-year to 684.67%; the TTM figure through Mar 2026 stood at 417.93% (changed N/A YoY), while the FY2025 annual figure was 633.21%, changed N/A from the prior year.
- EBITDA Margin came in at 684.67% for Q1 2026 at EBR Systems, down from 2411.82% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 2411.82% in Q4 2025 to a low of 6559.62% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | EBR Systems | - | - | 184,000.00 | -684.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -684.67% |
| Dec 31, 2025 | 2,411.82% |
| Sep 30, 2025 | -2,320.05% |
| Jun 30, 2025 | -6,559.62% |